Last reviewed · How we verify

NCT06950203

The Effect of Supplementation With Fish Oil (EPAX EVOLVE 05) on Sperm Quality

Recruiting now NA Last updated 1 May 2025
What this trial tests

NA trial testing Very Long Chain Polyunsaturated Fatty Acids in Infertility, Male in 80 participants. Currently enrolling.

Timeline
10 March 2025
Primary endpoint
1 September 2026
20 December 2026

Quick facts

Lead sponsorEpax Norway AS
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingquadruple
Primary purposeother
Enrollment80
Start date10 March 2025
Primary completion1 September 2026
Estimated completion20 December 2026
Sites1 location across Norway

Drugs / interventions tested

Conditions studied

Sponsor

Epax Norway AS

Who can join

Adults 18 to 55, male only, with Infertility, Male. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will enrol men that have a poor sperm quality. They will take either a placebo or fish oil capsule (2 per day) for 3 months. At the beginning and end of the study the participant will be asked for a sperm sample for measuring quality parameters.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Infertility, Male

Currently open trials in the same condition.

Other Epax Norway AS trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06950203.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing